New Technique Leads to Birth of Healthy Babies in Britain
In a noteworthy development, researchers in Britain have successfully delivered eight healthy babies using a cutting-edge technique that utilizes DNA from three individuals. This method aims to help mothers avoid transmitting serious, rare diseases to their offspring.
Typically, the majority of our DNA is located within the cell nucleus, which carries genetic information from both parents. However, DNA also exists in mitochondria, aligning outside of the nucleus. Mutations in mitochondrial DNA can lead to severe health issues in children, including muscle weakness, seizures, and even developmental delays that could be life-threatening.
While the in vitro fertilization (IVF) process can often detect these mutations, some cases remain unclear. To address this, scientists have developed a technique where healthy mitochondria from a donor egg are used to replace defective ones. In 2023, the first babies born using this revolutionary method were reported, involving the transfer of genetic material from the mother into a donor egg that has had its original DNA removed but retains healthy mitochondria.
Dr. Zev Williams, who leads the Columbia University Fertility Center, called this research an “important milestone,” emphasizing that it enhances reproductive options for couples seeking safe pregnancies.
This new approach means the babies have DNA derived from three sources: the mother, the father, and the donor. A law change in the U.K. back in 2016 made this possible, although similar techniques are not widely accepted in several countries, including the United States.
From 22 patients undergoing this procedure, researchers from Newcastle University and Monash University in Australia confirmed that eight babies were born healthy and appear free of mitochondrial diseases. One mother is still expecting.
Despite one newborn exhibiting slightly elevated levels of abnormal mitochondria, experts believe this level is not significant enough to cause health concerns. Dr. Andy Greenfield from the University of Oxford praised the initiative, indicating it would only be applied in cases where traditional embryo testing fails to prevent genetic diseases.
Importantly, the portion of DNA inherited from the donor is minimal, constituting less than 1% of the child’s total genetic makeup. This means children will not exhibit any characteristics from the donor of the healthy mitochondria, as highlighted by researcher Robin Lovell-Badge.
On the regulatory side, couples seeking this type of treatment in the U.K. must receive approval from the appropriate fertility authority. As of now, 35 applicants have been authorized to proceed with the technique.
However, concerns linger among critics regarding the potential implications of such innovative procedures on future generations. The debate continues, particularly in the United States where significant policy barriers currently limit the use of methods leading to genetic modifications that can be passed down.
Nevertheless, for families facing the despair of mitochondrial diseases, this technique holds promise. Liz Curtis, who lost her daughter Lily to such a condition in 2006, expressed enthusiasm for the new technology. After founding the Lily Foundation to support families impacted by mitochondrial diseases, she underscored that this advancement offers new hope for families who have long felt lost.
“It’s incredibly exciting for families who haven’t had much hope,” Curtis remarked.
